Natriuretic peptides in relation to the cardiac innervation and conduction system.
During the past two decades, the heart has been known to undergo endocrine action, harbouring peptides with hormonal activities. These, termed "atrial natriuretic peptide (ANP)," "brain natriuretic peptide (BNP)," and "C-type natriuretic peptide (CNP)," are polypeptides mainly produced in the cardiac myocardium, where they are released into the circulation, producing profound hypotensive effects due to their diuretic, natriuretic, and vascular dilatory properties. It is, furthermore, well established that cardiac disorders such as congestive heart failure and different forms of cardiomyopathy are combined with increased expression of ANP and BNP, leading to elevated levels of these peptides in the plasma. Besides the occurrence of natriuretic peptides (NPs) in the ordinary myocardium, the presence of ANP in the cardiac conduction system has been described. There is also evidence of ANP gene expression in nervous tissue such as the nodose ganglion and the superior cervical ganglion of the rat, ganglia known to be involved in the neuronal regulation of the heart. Furthermore, in the mammalian heart, ANP appears to affect the cardiac autonomic nervous system by sympathoinhibitory and vagoexcitatory actions. This article provides an overview of the relationship between the cardiac conduction system, the cardiac innervation and NPs in the mammalian heart and provides data for the concept that ANP is also involved in neuronal cardiac regulation.
Hansson
Magnus
M
Department of Integrative Medical Biology, Section for Anatomy and Department of Medical Biosciences, Section for Pathology, Umeå University, Umeå, Sweden. magnus.hansson@anatomy.umu.se
D000818:Animals; D009320:Atrial Natriuretic Factor / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D015415:Biomarkers / Q000097:blood; D009202:Cardiomyopathies / Q000378:metabolism; D006321:Heart / Q000294:innervation*; D006329:Heart Conduction System / Q000378:metabolism*; D006333:Heart Failure / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D008322:Mammals; D009206:Myocardium / Q000378:metabolism*; D020097:Natriuretic Peptide, Brain / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D020098:Natriuretic Peptide, C-Type / Q000032:analysis / Q000378:metabolism*; D009620:Nodose Ganglion / Q000378:metabolism; D017461:Receptors, Atrial Natriuretic Factor / Q000502:physiology; D017783:Superior Cervical Ganglion / Q000378:metabolism
D015415:Biomarkers; D020097:Natriuretic Peptide, Brain; D020098:Natriuretic Peptide, C-Type; D009320:Atrial Natriuretic Factor; D017461:Receptors, Atrial Natriuretic Factor